Поле DC | Значение | Язык |
dc.contributor.author | Larin, S. L. | - |
dc.contributor.author | Zvyagintseva, A. R. | - |
dc.contributor.author | Habarov, A. A. | - |
dc.contributor.author | Budko, E. V. | - |
dc.date.accessioned | 2022-04-29T10:14:06Z | - |
dc.date.available | 2022-04-29T10:14:06Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Experimental investigation of pharmacokinetic properties and the accumulation of zinc when administrated nanoform of zinc hydroxide in a comparative aspect with zinc sulfate / S. L. Larin [et al.] // Research result: pharmacology and clinical pharmacology. - 2016. - Vol. 2, № 4.- P. 21-33. - Doi: 10.18413/2500-235X -2016-2-4-21-33. - Refer.: p. 33. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46535 | - |
dc.description.abstract | The purpose of a preliminary assessment of the biological effect, a comparative study of nanoparticles using test cultures of bakery yeast, the results of which determined the level of inhibition, which was higher than 90%, compared with the figure for the zinc sulfate and the above 145% more compared to the zinc oxide. Investigation was performed on the pharmacokinetic characteristics of the 40 rabbits-males in comparison with that using zinc sulfate, in an enteral or intravenous administration at three dose levels: 10, 50 and 100 mg/kg | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | pharmacokinetics | ru |
dc.subject | zoology | ru |
dc.subject | physiology of animals | ru |
dc.subject | zinc | ru |
dc.subject | nanoparticles | ru |
dc.subject | zinc hydroxide | ru |
dc.subject | zinc sulfate | ru |
dc.subject | zinc oxide | ru |
dc.subject | accumulation | ru |
dc.title | Experimental investigation of pharmacokinetic properties and the accumulation of zinc when administrated nanoform of zinc hydroxide in a comparative aspect with zinc sulfate | ru |
dc.type | Article | ru |
Располагается в коллекциях: | Vol. 2, № 4
|